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I should like to begin by discussing the present condition of biomedical science.
Viewed from the outside, the biomedical research activities in this country, in both
clinical and laboratory science, give the impression of steady and solid financial
support. In one sense the impression is accurate, since the institutions have received
generous backing from the National Institutes of Health since their inception. Many
of them have received, at the same time, varying amounts of support from state and
local governments and from private philanthropic sources.
However, the situation in which the country's research institutions find themselves
today has nothing at all like stability, much less predictability for the near-term
future. After a two-decade period of spectacular expansion of a very broad range of
scientific programs, mainly under NIH sponsorship, the federal sources of funds
have begun to level off on a flat line. It is now the almost certain prospect that
future funding will be held at about its present level, even decreasing somewhat
each year due to inflation. Meanwhile, the proportion of the total cost of scientific
programs supported by funds from private sources has steadily decreased in recent
years.
At present, the federal government funds account for well over 75 percent of the
research costs of most American research institutions. Almost all of this support has
been generated by individual scientists, workingsingly and in small groups, with each
research project subjected to the closest critical scrutiny by peer-review committees
from the outside, and in the face ofthe most intense competition from other research
centers across the country.
The future holds a considerably more chancy outlook. It is by no means as certain
as it seemed a few years back that biomedical research will continue to be a uniquely
privileged federal program, with the same high priority for the administration or the
Congress, in view of the competing demands for more federal funds for energy,
environmental salvage, urban decay and the like. We will be fortunate, in the
informed view of some, if the level of support can simply be held at today's figure
without decline. This means that not only will it be necessary to control our costs
with the severest discipline but, unless new sources offunds can be obtained from the
private sector, we will have to begin reducing or even eliminating research programs.
The latter is an eventuality nearly impossible to contemplate, not because pro-
grams cannot be cut out at any time, but because from the point of view of sheer
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All rights of reproduction in any form reserved.scientific opportunity this is the very worst of times to be thinking of reducing the
effort. There has never before been a time of such intellectual excitement and
optimism. New leads seem to be turning up all over the place. The search, necessarily
delayed for so many years because of absent knowledge and no visible clues, has
suddenly turned into a running hunt. New knowledge is coming in cascades, from
laboratories all around the world, and there are clues at every hand that could not
have been imagined five years ago. It is no time to shut things down.
There are two great difficulties posed by the disproportion between federal and
private institutional support, even if the former is maintained at adequate levels. The
first is the fundamental problem of predictability: there is no certainty, in any given
year, that the scientific direction to be favored within the federal bureaucracy, and
the funds to be allocated, may not be shifted drastically on political grounds in the
year to follow, leavingongoing programs ofvital concern to the scientific community
within the Center beached and stranded. Second, there is an increasing tendency,
understandable enough at a time of so much competition for a diminishing pool of
federal funds, which favors the award of grant support to "safe and sound" research
programs. This means that it will henceforth be much more difficult to obtain
support for scientific "gambles." It is a particularly dismaying prospect, since a
backward look at the record of biomedical science in this century should convince
anyone that the major advances have been made, almost without exception, by what
seemed at the time to be gambling on an unlikely hypothesis.
Perhaps the greatest of all the difficulties now confronting the biomedical science
enterprise in America is in the area of public understanding. The scientific commu-
nity has not, I fear, been very skilled at explaining what it is up to, nor has it tended
to be sufficiently candid about its own limitations as far as medicine is concerned. As
a result, the most unrealistic expectations for the rapid cure and elimination of
disease were allowed to arise, even fostered, and there are now clear signs of the
predictable reaction: disenchantment withscience in general and with medical science
in particular, and a growing anxiety about what are perceived by some as the negative
results of science.
I believe that the record thus far established in the relatively brief history of
research in medicine has demonstrated that biomedical science has been, on balance,
of enormous benefit to human beings although it is still in a much earlier stage ofits
development than the public has been led to believe. But it is important to say, in
candor, that you cannot edit science in advance, and youcertainly cannot censor it. It
is in the nature of the scientific enterprise that you cannot predict how it is going to
turn out. You cannot make choices in this matter, selecting things you think you're
going to like and shutting off the lines that seem unpopular. You either have science
or you don't, and if you have it you are obliged to accept the surprising and
disturbing bits of information, even the overwhelming and upheaving ones, along
with the neat and promptly useful bits. It is like that.
On balance, though, the record then far set by science in medicine is a lot more
reassuring than you'd think to read the papers.
Medicine has always raised the highest expectations from society, at whatever
time, as far back as the Indo-European roots from which the profession takes its
name. Just look at the words we use for boasting about ourselves and what we do!
Med was a word indicating measurement, apportionment, and the term medicine
suggested taking appropriate measures but also meant some precision and
exactitude-indicating that the measures taken were expected to be precisely the
right ones needed for curing the disease. The doctor came from dek, meaning to
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teach, with the implication that this professional, practicing the art of medicine, not
only knew precisely what to measure out for an illness, but could teach us all how to
live a life.
These are heavy terms indeed, and the meaning inside them continues to resonate
there, burdening medicine, and doctors, with an enormous responsibility that the
profession has struggled to carry off convincingly for century after century.
Now it is in trouble, for a complexity of reasons. It is supposed to be all the things
it used to be, plus a science as well.
It is this latter complication, the introduction of science into the discipline, that I
want to talk about here, for I believe there is a quite general misunderstanding about
the level to which science has matured in medicine, and especially about where
science might be taking us for the future. To begin the discussion, it is necessary to
take a quick look back, to see where we've come from.
It is customary to place the date for the beginnings ofmodern medicine somewhere
in the mid-1930s, with the entry of sulfonamides and penicillin into the pharma-
copoeia, and it is usual to ascribe to these events the force of a revolution in medical
practice. This is what things seemed like at the time. Medicine was upheaved,
revolutionized indeed. Therapy had been discovered for great numbers of patients
whose illnesses had previously been untreatable. Cures were now available. As we
saw it then, it seemed a totally new world. Doctors could now cure disease, and this
was astonishing, most of all to the doctors themselves.
It was, no doubt about it, a major occurrence in medicine, and a triumph for
biological science applied to medicine but perhaps not a revolution after all, looking
back from this distance. For the real revolution in medicine, which set the stage for
antibiotics and whatever else we have in the way of effective therapy today, had
already occurred 100 years before penicillin. It did not begin with the introduction of
science into medicine. That came years later. Like a good many revolutions, this one
began with the destruction of dogma. It was discovered, sometime in the 1830s, that
the greater part of medicine was nonsense.
The history of medicine has never been a particularly attractive subject in medical
education, and one reason for this is that it is so deplorable a story. For centuryafter
century, all the way into the remote millennia of its origins, medicine got along by
sheer guesswork and the crudest sort of empiricism. It is hard to conceive of a less
scientific enterprise among human endeavors. Virtually anything that could be
thought up for the treatment of disease was tried out at one time or another, and,
once tried, lasted decades or even centuries before being given up. It was, in
retrospect, the most frivolous and irresponsible kind of human experimentation,
based on nothing but trial and error and usually resulting in precisely that sequence.
Bleeding, purging, cupping, the administration of infusions of every known plant,
solutions of every known metal, every conceivable diet including total fasting, most
ofthese based on the weirdest imaginings about the cause ofdisease, concocted out of
nothing but thin air-this was the heritage of medicine up until a little over a century
ago. It is astounding that the profession survived so long, and got awaywith so much
with so little outcry. Almost everyone seems to have been taken in. Evidently one had
to be a born skeptic, like Montaigne, to see through the old nonsense; but even
Montaigne, who wrote scathingly about the illnesses caused by doctoring centuries
before Ivan Illich, had little effect. Most people were convinced ofthemagical powers
of medicine and put up with it. Medicine was, in truth, a kind of superstition.
Then, sometime in the early nineteenth century, it was realized by a few of the
leading figures in medicine that almost all of the complicated treatments then
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courageous physicians that most of them actually did more harm than good.
Simultaneously, the surprising discovery was made that certain diseases were self-
limited, got better by themselves, possessed, so to speak, a "natural history." It is
hard for us now to imagine the magnitude of this discovery and its effect on the
practice of medicine. The long habit of medicine, extending back into the distant
past, had been to treat everything with something, and it was taken for granted that
every disease demanded treatment and might in fact end fatally if not treated. In a
sober essay written on this topic in 1876, Professor Edward H. Clarke of Harvard
reviewed what he regarded as the major scientific accomplishment ofmedicine in the
preceding fifty years, which consisted of studies proving that patients with typhoid
and typhus fever could recover all by themselves, without medical intervention, and
often did better for being untreated than when they received the bizarre herbs, heavy
metals and fomentations that were popular at that time. Delirium tremens, a disorder
long believed to be fatal in all cases unless subjected to constant and aggressive
medical intervention, was observed to subside by itself more readily in patients left
untreated, with a substantially improved rate of survival.
Gradually, over the succeeding decades, the traditional therapeutic ritual of
medicine was given up, and what came to be called the "art of medicine" emerged to
take its place. In retrospect, this art was really the beginning of the science of
medicine. It was based on meticulous, objective, even cool observations of sick
people. From this endeavor we learned the details of the natural history of illness, so
that, for example, it came to be understood that typhoid and typhus were really two
entirely separate, unrelated disorders, with quite different causes. Accurate diagnosis
became the central purpose and justification for medicine, and as the methods for
diagnosis improved, accurate prognosis also became possible, so that patients and
their families could be told not only the name of the illness but also, with some
reliability, how it was most likely to turn out. By the time this century had begun,
these were becoming generally accepted as the principal responsibilities of the
physician. In addition, a new kind of much less ambitious and flamboyant therapy
began to emerge, termed supportive treatment and consisting in large part of plain
common sense: good nursing care, appropriate bed rest, a sensible diet, avoidance of
traditional nostrums and patent medicine, and a measured degree of trust that
nature, in taking its course, would very often bring things to a satisfactory conclu-
sion.
The doctor became a considerably more useful and respected professional. For all
his limitations, and despite his inability to do much in the way of preventing or
terminating illness, he could be depended on to explain things, to relieve anxieties,
and to be on hand. He was trusted as an advisor and guide in difficult times,
including the time of dying.
Meanwhile, starting in the last decade of the nineteenth century, the basic science
needed for a future science of medicine got under way. The role of bacteria and
viruses in illness was discerned, and research on the details of this connection began
in earnest. The major pathogenic organisms, most notably the tubercle bacillus and
the syphilis spirochete, were recognized for what they were and did. By the late 1930s
this research had already paid off; the techniques ofactive and passive immunization
had been worked out for diphtheria, tetanus, lobar pneumonia and a few other
bacterial infections; the taxonomy of infectious disease had become an orderly
discipline; and the time was ready for sulfanilamide, penicillin, streptomycin, and all
the rest. But itneeds emphasizing that it took aboutfiftyyears ofconcentrated effort
in basic research to reach this level; ifthis research had not been done we could not
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have guessed that streptococci and pneumococci exist, and the search for antibiotics
would have made no sense at all. Without the long, painstaking research on the
tubercle bacillus, we would still be thinking that tuberculosis was due to night air and
we would still be trying to cure it by sunlight.
At that time, after almost a century of modified skepticism about therapy
amounting finally to near nihilism, we abruptly entered a new era in which, almost
overnight, it became possible with antibiotics to cure outright some of the most
common and lethal illnesses of human beings-lobar pneumonia, meningitis, ty-
phoid, typhus, tuberculosis, septicemias of various types. Only the virus diseases lay
beyond reach, and even some of these were shortly to come under control-as in
poliomyelitis and measles-by new techniques for making vaccines.
These events were simply overwhelming when they occurred. I was a medical
student at the time of sulfanilamide and penicillin, and I remember the earliest
reaction of flat disbelief concerning such things. We had given up on therapy, a
century earlier. With a few exceptions which we regarded as anomalies, such as
Vitamin B for pellagra, liver extract for pernicious anemia, and insulin for diabetes,
we were educated to be skeptical about the treatment of disease. Miliary tuberculosis
and subacute bacterial endocarditis were fatal in 100 percent of cases, and we were
convinced that the course of master diseases like these could never be changed, not in
our lifetime or in any other.
Overnight, we became optimists, enthusiasts. The realization that disease could be
turned around by treatment, provided that one knew enough about the underlying
mechanism, was a totally new idea just forty years ago.
Most people have forgotten about that time, or are too young to remember it, and
tending now to take such things for granted. They were born knowing about
antibiotics, or the drugs simply fell by luck into their laps. We need reminding, now
more than ever, that the capacity of medicine to deal with infectious diseases was not
a lucky fluke, nor was it something that happened simply as the result ofthe passage
of time. It was the direct outcome of many years of hard work, done by imaginative
and skilled scientists, none of whom had the faintest idea that penicillin and
streptomycin lay somewhere in the decades ahead. It was basic science ofa very high
order, storing up a great mass of interesting knowledge for its own sake, creating, so
to speak, a bank of information, ready for drawing on when the time for intelligent
use arrived.
For example, it took a great deal of time, and work, before it could be understood
that there were such things as hemolytic streptococci, that there were more than forty
different serological types of the principal streptococcal species responsible for
human disease, and that some of these were responsible for rheumatic fever and
valvular heart disease. The bacteriology and immunology had to be done first, over
decades, and by the early 1930s the work had progressed just far enough so that the
connection between streptococcal infection and rheumatic fever could be perceived.
Not until this information was at hand did it become a certainty that rheumatic
fever could be prevented, and with it a large amount of the chief heart disease
affecting young people, if only a way could be found to prevent streptococcal
infection. Similarly, the identification of the role of pneumococci in lobar pneumo-
nia, of brucellae in undulant fever, typhoid bacilli in typhoid fever, the meningococ-
cus in epidemic meningitis, required the sorting out and analysis of what seemed at
the time an immensely complicated body of information. Most of the labor in
infectious disease laboratories went into work of this kind in the first third of this
century. When it was finished, the scene was ready for antibiotics.
What was not realized then and is not fully realized even now was how difficult it
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heart disease, cancer, stroke, schizophrenia, arthritis, kidney failure, cirrhosis and the
degenerative diseases associated with aging. All told there is a list of around twenty-
five major afflictions of man in this country, and a still more formidable list of
parasitic, viral and nutritional diseases in the less developed countries of the world,
which make up the unfinished agenda of modern biomedical science.
How does one make plans for science policy with such a list? The quick and easy
way is to conclude that thesediseases, not yet mastered, are simply beyond our grasp.
The thing to do is to settle down with today's versions of science and technology, and
make sure that our health caresystem is equipped to do the best it can in an imperfect
world. The trouble with this approach is that we cannot afford it. The costs are
already too high, and they escalate higher each year. Moreover, the measures
available are simply not good enough. We cannot go on indefinitely trying to cope
with heart disease by open-heart surgery, carried out at formidable expense after the
disease has run its destructive course. Nor can we postpone such issues by oversimpli-
fying the problems, which is what we do, in my opinion, by attributing so much of
today's chronic and disabling disease to the environment, or to wrong ways of living.
The plain fact of the matter is that we do not know enough about the facts of the
matter, and we should be more open about our ignorance.
At the same time and this will have a paradoxical sound, there has never been a
period in medicine when the future has looked so bright. There is within medicine,
somewhere beneath the pessimism and discouragement resulting from the disarray of
the health care system and its stupendous cost, an undercurrent of almost outrageous
optimism about what may lie ahead for the treatment of human disease ifwe can only
keep learning. The scientists who do research on the cardiovascular system are
entirely confident that they will soon be working close to the center of things, and
they no longer regard the mechanisms of heart disease is impenetrable mysteries. The
cancer scientists, for all their public disagreements about how best to organize their
research, are in possession of insights into the intimate functioning of normal and
neoplastic cells that were unimaginable a few years back. The eukaryotic cell, the cell
with a true nucleus, has itself become a laboratory instrument almost as neat and
handy as the bacterial cell became in the early 1950s, ready now to be used for
elucidating the mechanisms by which genes are switched on or off as developing cells
differentiate or, as in the case of cancer cells, de-differentiate. The ways in which
carcinogenic substances, or viruses, or other factors still unrecognized intervene in
the regulation of cell behavior represent problems still unsolved, but the problems
themselves now appear to be approachable; with what has been learned in the past
decade, they can now be worked on.
The neurobiologists can do all sorts ofthings in their investigation, and the brain is
an organ different from what it seemed twenty-five years ago. Far from being an
intricate but ultimately simplifiable mass of electronic circuitry governed by wiring
diagrams, it now has the aspect of a fundamentally endocrine tissue, in which the
essential reactions, the internal traffic of nerveimpulses, are determined by biochemi-
cal activators and theirsuppressors. Thetechnologies available for quantitative study
of individual nerve cells are powerful and precise, and the work is now turning
toward the functioning of collections of cells, the centers for visual and auditory
perception and the like, because work at this level can now be done. It is difficult to
think ofproblems that cannot be studied, ever. The matter ofconsciousness is argued
over, naturally, as a candidate forperpetual unapproachability, but this has more the
sound of a philosophical discussion. Nobody has thefeeling any longer, as we used to
believe, that we can never find out how the brain works.
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The immunologists, the molecular biochemists and the new generation of investi-
gators obsessed with the structure and function ofcell membranes have all discovered
that they are really working together, along with the geneticists, on a common set of
problems: how do cells and tissues become labeled for what they are, what are the
forces that govern the orderly development and differentiation oftissues and organs,
and how are errors in the process controlled?
There has never been a time like it, and I find it difficult to imagine that this
tremendous surge of new information will terminate with nothing more than an
understanding ofhow normal cells and tissues, and organisms, function. I regard it as
a certainty that there will be uncovered, at the same time, detailed information
concerning the mechanisms of disease.
The record of the past half-century has established, I think, two general principles
about human disease. First, it is necessary to know a great deal about underlying
mechanisms before one can really act effectively; one had to know that the
pneumococcus causes lobar pneumonia before one could begin thinking about
antibiotics. One did not have to know all the details, not even how the pneumococcus
does its damage to the lungs, but one had to know that it was there, and in charge.
Second, for everydisease there is a single key mechanism that dominates all others.
If one can find it, and then think one's way around it, one can control the disorder.
This generalization is harder to prove, and arguable-it is more like a strong hunch
than a scientific assertion-but I believe that the record thus far tends to support it.
The most complicated, multicell, multitissue, and multiorgan diseases I know of are
tertiary syphilis, chronic tuberculosis and pernicious anemia. In each, there are at
least five major organs and tissues involved, and each appears to be affected by a
variety of environmental influences. Before they came under scientific appraisal each
was thought to be what we now call a "multi-factorial" disease, far too complex to
allow for any single causative mechanism. And yet, when all the necessaryfacts were
in, it was clear that by simply switching off one thing-the spirochete, the tubercle
bacillus, or a single vitamin deficiency-the whole array ofdisordered and seemingly
unrelated pathologic mechanisms could be switched off,, at once.
I believe that a prospect something like this is the likelihood for the future of
medicine. I have no doubt that there will turn out to be dozens ofseparate influences
that can launch cancer, including all sorts of environmental carcinogens and very
likely many sorts of virus, but I think there will turn out to be a single switch at the
center ofthings, there for the finding. I think that schizophrenia will turn out to be a
neurochemical disorder, with some central, single chemical event gone wrong. I think
there is a single causative agent responsible for rheumatoid arthritis, which has not
yet been found. I think that the central vascular abnormalities that launch coronary
occlusion and stroke have not yet been clearly glimpsed, but they are there, waiting to
be switched on or off, perhaps by capitalizing on the new field opened up by
Samuelson, of endoperoxides and thromboxanes.
In short, I believe that the major diseases of human beings have become ap-
proachable biological puzzles, ultimately solvable. It follows from this that it is now
possible to begin thinking about a human society relatively free of disease. This
would surely have been an unthinkable notion a half century ago, and oddly enough
it has a rather apocalyptic sound today. What will we do about dying, and about all
that population, if such things were to come about? What can we die of, if not
disease?
My response is that it would not make all that much difference. We would still age
away and wear out, on about the same schedule as today, with the terminal event
being more like the sudden disintegration and collapse all at once of Oliver Wendell
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almost pure benefit it seems to me, would be that we would not be beset and raddled
by disease in the last decades of life, as most of us are today. We could become a
healthy species, not all that different from the healthy stocks of domestic plants and
animals that we already take for granted. Strokes, and senile dementia, and cancer
and arthritis are not natural aspects of the human condition, and we ought to rid
ourselves of such impediments as quickly as we can.
There is another argument against this view of the future which needs comment. It
is said that we are fundamentally fallible as organisms, prone to failure, and if we
succeed in getting rid of one set of ailments there will always be other new diseases,
now waiting out in the forest, ready to take their places. I do not know why this is
said, for I can see no evidence that such a thing has ever happened. To be sure, we
have a higher incidence of chronic illness among older people than we had in the early
years of this century, but that is because more of us have survived to become older
people. No new disease, so far as I know, has come in to take the place ofdiphtheria,
or smallpox, or whooping cough, or poliomyelitis. Nature being inventive, we will
probably always have the odd new illness turning up, but not in order to fill out some
ordained, predestined quota of human maladies.
Indeed, the official public health tables of morbidity and mortality seem to be
telling us this sort ofthing already, even though, in all our anxiety, we seem unwilling
to accept the news. We have already become in the Western world, on the record, the
healthiest society in the history of humankind. Compared with a century ago, when
every family was obliged to count on losing members throughout the early years of
life, we are in a new world. A death in a youngfamily has become a rare and dreadful
catastrophe, no longer a commonplace event. Our estimated life expectancy, collec-
tively, is longer this year than ever before in history. Part of this general and gradual
improvement in health and survival is thanks to sanitary engineering, better housing
and, probably, more affluence, but a substantial part is also attributable, in recent
years, to biomedical science. We have not done badly at all, and having begun so well
I see no reason why we should not do even better in the future.
My argument about how to do this will come as no surprise. I say that we must
continue doing biomedical research, on about the same scale and scope as in the past
twenty years, with expansion and growth of the enterprise being dependent on where
new leads seem to be taking us. It is an expensive undertaking, but still it is less than 3
percent of the total annual cost of today's health industry, which at last count was
over $130 billion, and it is nothing like as expensive as trying to live with the halfway
technologies we are obliged to depend on in medicine today; if we try to stay with
these for the rest of the century the costs will go through the ionosphere.
But I should like to insert a qualification in this argument, which may be somewhat
more ofa surprise, coming from a doctor. I believe that the major research effort, and
far and away the greatest investment for the future, must be in the broad area ofbasic
biological science. Here and there, to be sure, there will be opportunities for
productive applied science, comparable, say, to the making of polio vaccine or the
devising of multidrug therapy for childhood leukemia, but these opportunities will
not come often, nor can they be forced into existence before their time. The great
need now, for the medicine of the future, is for more information at the most
fundamental levels of the living process. We are nowhere near ready for large-scale
programs of applied science in medicine, for we do not yet know enough.
Good applied science in medicine, as in physics, requires a high degree of certainty
about the basicfacts at hand, and especially about their meaning, and we have not yet
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reached this point for most of medicine. Nor can we predict at this stage, with much
confidence, which particular items of new information, from which fields, are the
likeliest to be relevant to particular disease problems. In this circumstance there has
to be a certain amount of guessing, even gambling, and my own view is that the
highest yield for the future will come from whatever fields are generating the most
interesting, exciting and surprising sorts of information, most of all, surprising.
It seems to me that the safest and most prudent of bets to lay money on is surprise.
There is a very high probability that whatever astonishes us in biology today will turn
out to be usable, and useful, tomorrow. This, I think, is the established record of
science itself, over the past two hundred years, and we ought to have more
confidence in the process. It worked this way for the beginnings of chemistry; we
obtained electricity in this manner; using surprise as a guide we progressed from
Newtonian physics to electromagnetism, to quantum mechanics and contemporary
geophysics and cosmology. In biology, evolution and genetics were the earliest big
astonishments, but what has been going on in the past quarter century is simply
flabbergasting. For medicine, the greatest surprises lie still ahead of us, but they are
there, waiting to be discovered or stumbled over, sooner or later.
I am arguing this way from the most practical, down-to-earth, pragmatic point of
view. This kind of science is most likely, in the real world, to lead to significant
improvements in human health, and at low cost. This is a point worth further
emphasis, by the way. When medicine has really succeeded brilliantly in technology,
as in immunization, for example, or antibiotics, or nutrition, or endocrine replace-
ment therapy, so that the therapeutic measures can be directed straight at the
underlying disease mechanism and are decisively effective, the cost is likely to be very
low indeed. It is when our technologies have to be applied halfway along against the
progress of disease, or must be brought in after the fact to shore up the loss of
destroyed tissue, that health care becomes enormously expensive. The deeper our
understanding of a disease mechanism, the greater are our chances of devising direct
and decisive measures to prevent disease, or to turn it around before it is too late.
So much for the practical side of the argument. We need much more basic science
for the future of human health, and I will leave the matter there.
But I have one last thing to say about biological science. Even if I should be wrong
about some of these predictions, and it turns out that we can blunder our way into
treating or preventing one disease or another without understanding the process
(which I will not believe until it happens), and if we continue to invest in biological
science anyway, we cannot lose. The Congress in its wisdom, cannot lose. The public
cannot lose.
Here is what I have in mind.
These ought to be the best oftimes for the human mind, but it is not so. All sorts of
things seem to be turning out wrong, and the century seems to be slipping through
our fingers here at the end, with almost all promises unfilled. I cannot begin to guess
at all the causes of our cultural sadness, not even the most important ones, but I can
think of one thing that is wrong with us and eats away at us: we do not know enough
about ourselves. We are ignorant about how we work, about where we fit in, and
most of all about the enormous, imponderable system of life in which we are
embedded as working parts. We do not really understand nature, at all. Not to
downgrade us; we have come a long way indeed, but just to learn enough to become
conscious of our ignorance. It is not so bad a thing to be totally ignorant; the hard
thing is to be part way along toward real knowledge, far enough to be aware of being
ignorant. It is embarrassing and depressing, and it is one of our troubles today.
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everything about everything, out of pure reason, and now most ofthat elaborate and
harmonious structure has come apart before our eyes. We are dumb.
This is, in a certain sense, a health problem after all. For as long as we are
bewildered by the mystery of ourselves, and confused by the strangeness of our
uncomfortable connection to all the rest of life, and dumbfounded by the incompre-
hensibility of our own minds, we cannot be said to be healthy animals in today's
world.
We need to know more. To come to realize this is what this seemingly inconclusive
century has been all about. We have discovered how to ask important questions, and
now we really do need, as an urgent matter, for the sake ofour civilization, to obtain
some answers. We now know that we cannot do this any longer by searching our
minds, for there is not enough there to search, nor can we find the truth by guessing
at it or by making up stories for ourselves. We cannot stop where we are, stuck with
today's level of understanding, nor can we go back. I do not see that we have a real
choice in this, for I can see only the one way ahead. We need science, more and better
science, not for its technology, not for leisure, not even for health or longevity, but
for the hope of wisdom which our kind of culture must acquire for its survival.
Lewis Thomas, M.D.
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